Pfizer Inc. has announced a notable increase in its second-quarter earnings for 2025, reporting adjusted earnings of 78 cents per share, up from 60 cents a...
Consumers navigating the complexities of Medicare Part D often face significant challenges, particularly regarding prescription drug coverage. Joel Mekler highlights the dual categories of issues that...
